BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 9888439)

  • 1. VEGF-induced permeability increase is mediated by caveolae.
    Feng Y; Venema VJ; Venema RC; Tsai N; Behzadian MA; Caldwell RB
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):157-67. PubMed ID: 9888439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF induces nuclear translocation of Flk-1/KDR, endothelial nitric oxide synthase, and caveolin-1 in vascular endothelial cells.
    Feng Y; Venema VJ; Venema RC; Tsai N; Caldwell RB
    Biochem Biophys Res Commun; 1999 Mar; 256(1):192-7. PubMed ID: 10066445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis.
    Sonveaux P; Martinive P; DeWever J; Batova Z; Daneau G; Pelat M; Ghisdal P; Grégoire V; Dessy C; Balligand JL; Feron O
    Circ Res; 2004 Jul; 95(2):154-61. PubMed ID: 15205364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells.
    Kroll J; Waltenberger J
    Biochem Biophys Res Commun; 1999 Nov; 265(3):636-9. PubMed ID: 10600473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties.
    Chang YS; Munn LL; Hillsley MV; Dull RO; Yuan J; Lakshminarayanan S; Gardner TW; Jain RK; Tarbell JM
    Microvasc Res; 2000 Mar; 59(2):265-77. PubMed ID: 10684732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide.
    Wang J; Morita I; Onodera M; Murota SI
    J Cell Physiol; 2002 Feb; 190(2):238-50. PubMed ID: 11807828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vascular endothelial growth factor on nitric oxide production by cultured rat mesangial cells.
    Trachtman H; Futterweit S; Franki N; Singhal PC
    Biochem Biophys Res Commun; 1998 Apr; 245(2):443-6. PubMed ID: 9571172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR).
    Kroll J; Waltenberger J
    Biochem Biophys Res Commun; 1998 Nov; 252(3):743-6. PubMed ID: 9837777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of VEGF on retinal microvascular endothelial hydraulic conductivity: the role of NO.
    Lakshminarayanan S; Antonetti DA; Gardner TW; Tarbell JM
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4256-61. PubMed ID: 11095623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
    Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O
    Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway.
    Shen BQ; Lee DY; Zioncheck TF
    J Biol Chem; 1999 Nov; 274(46):33057-63. PubMed ID: 10551875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide mediates the mitogenic effects of insulin and vascular endothelial growth factor but not of leptin in endothelial cells.
    Józkowicz A; Pankiewicz J; Dulak J; Partyka L; Wybrańska I; Huk I; Dembińska-Kieć A
    Acta Biochim Pol; 1999; 46(3):703-15. PubMed ID: 10698278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous production of nitric oxide by vascular endothelial growth factor down-regulates proliferation of choriocarcinoma cells.
    Cha MS; Lee MJ; Je GH; Kwak JY
    Biochem Biophys Res Commun; 2001 Apr; 282(4):1061-6. PubMed ID: 11352660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17 Beta-estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells.
    Suzuma I; Mandai M; Takagi H; Suzuma K; Otani A; Oh H; Kobayashi K; Honda Y
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2122-9. PubMed ID: 10440269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
    Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways.
    Lal BK; Varma S; Pappas PJ; Hobson RW; Durán WN
    Microvasc Res; 2001 Nov; 62(3):252-62. PubMed ID: 11678628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor fails to acutely modulate endothelial permeability during early angiogenesis in the chick chorioallantoic membrane.
    DeFouw LM; DeFouw DO
    Microvasc Res; 2000 Nov; 60(3):212-21. PubMed ID: 11078637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
    Tilton RG; Chang KC; LeJeune WS; Stephan CC; Brock TA; Williamson JR
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
    Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE
    Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF-dependent signaling in retinal microvascular endothelial cells.
    Enaida H; Kabuyama Y; Oshima Y; Sakamoto T; Kato K; Kochi H; Homma Y
    Fukushima J Med Sci; 1999 Dec; 45(2):77-91. PubMed ID: 11039605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.